AQA-0622

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAQA-0622
Drug Alias NameAQA-0622
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsWet age-related macular degenerationMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAquavit Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAquavit Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsWet age-related macular degenerationMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A